PHS
IMMU

PFM Health Sciences’s Immunomedics Inc IMMU Stock Holding History

PFM Health Sciences’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,343,570
Closed -$114M – 110
2020
Q3 		$114M Sell
1,343,570
-1,835,404
-58% -$92.8M 5.28% 2
2020
Q2 		$113M Buy
3,178,974
+2,114,933
+199% +$61.8M 5.84% 1
2020
Q1 		$14.3M Sell
1,064,041
-435,198
-29% -$7.32M 1.18% 33
2019
Q4 		$31.7M Buy
+1,499,239
New +$26.4M 1.51% 24

PFM Health Sciences's IMMU Position: Q4 2020 in Review

PFM Health Sciences sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,343,570 shares — an estimated $114M sold.

PFM Health Sciences first reported a position in IMMU in Q4 2019 and held it in 4 quarters. The position peaked at $114M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • PFM Health Sciences reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • PFM Health Sciences sold 1,343,570 Immunomedics Inc shares in Q4 2020, an estimated $114M.
  • PFM Health Sciences first reported a position in Immunomedics Inc in Q4 2019 and held it in 4 quarters.
  • PFM Health Sciences's Immunomedics Inc position peaked at $114M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on PFM Health Sciences's 13F filing for Q4 2020, filed 16 Feb 2021.